Global Gastrointestinal Stromal Tumor Market Size, Status and Forecast 2019-2025

1 Report Overview

• 1.1 Study Scope
• 1.2 Key Market Segments
• 1.3 Players Covered: Ranking by Gastrointestinal Stromal Tumor Revenue
• 1.4 Market by Type
  • 1.4.1 Global Gastrointestinal Stromal Tumor Market Size Growth Rate by Type: 2020 VS 2026
  • 1.4.2 Stomach
  • 1.4.3 Small Intestine
  • 1.4.4 Others
• 1.5 Market by Application
  • 1.5.1 Global Gastrointestinal Stromal Tumor Market Share by Application: 2020 VS 2026
  • 1.5.2 Hospitals
  • 1.5.3 Clinics
  • 1.5.4 Specialized Cancer Treatment Centers
  • 1.5.5 Other End Users
• 1.6 Study Objectives
• 1.7 Years Considered

2 Global Growth Trends

• 2.1 Global Gastrointestinal Stromal Tumor Market Perspective (2015-2026)
• 2.2 Global Gastrointestinal Stromal Tumor Growth Trends by Regions
  • 2.2.1 Gastrointestinal Stromal Tumor Market Size by Regions: 2015 VS 2020 VS 2026
  • 2.2.2 Gastrointestinal Stromal Tumor Historic Market Share by Regions (2015-2020)
  • 2.2.3 Gastrointestinal Stromal Tumor Forecasted Market Size by Regions (2021-2026)
• 2.3 Industry Trends and Growth Strategy
  • 2.3.1 Market Top Trends
  • 2.3.2 Market Drivers
  • 2.3.3 Market Challenges
  • 2.3.4 Porter’s Five Forces Analysis
  • 2.3.5 Gastrointestinal Stromal Tumor Market Growth Strategy
  • 2.3.6 Primary Interviews with Key Gastrointestinal Stromal Tumor Players (Opinion Leaders)

3 Competition Landscape by Key Players

• 3.1 Global Top Gastrointestinal Stromal Tumor Players by Market Size
  • 3.1.1 Global Top Gastrointestinal Stromal Tumor Players by Revenue (2015-2020)
  • 3.1.2 Global Gastrointestinal Stromal Tumor Revenue Market Share by Players (2015-2020)
  • 3.1.3 Global Gastrointestinal Stromal Tumor Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
• 3.2 Global Gastrointestinal Stromal Tumor Market Concentration Ratio
  • 3.2.1 Global Gastrointestinal Stromal Tumor Market Concentration Ratio (CR5 and HHI)
  • 3.2.2 Global Top 10 and Top 5 Companies by Gastrointestinal Stromal Tumor Revenue in 2019
• 3.3 Gastrointestinal Stromal Tumor Key Players Head office and Area Served
• 3.4 Key Players Gastrointestinal Stromal Tumor Product Solution and Service
• 3.5 Date of Enter into Gastrointestinal Stromal Tumor Market
• 3.6 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type (2015-2026)

• 4.1 Global Gastrointestinal Stromal Tumor Historic Market Size by Type (2015-2020)
• 4.2 Global Gastrointestinal Stromal Tumor Forecasted Market Size by Type (2021-2026)

5 Market Size by Application (2015-2026)

• 5.1 Global Gastrointestinal Stromal Tumor Market Size by Application (2015-2020)
• 5.2 Global Gastrointestinal Stromal Tumor Forecasted Market Size by Application (2021-2026)

6 North America

• 6.1 North America Gastrointestinal Stromal Tumor Market Size (2015-2020)
• 6.2 Gastrointestinal Stromal Tumor Key Players in North America (2019-2020)
• 6.3 North America Gastrointestinal Stromal Tumor Market Size by Type (2015-2020)
• 6.4 North America Gastrointestinal Stromal Tumor Market Size by Application (2015-2020)

7 Europe

• 7.1 Europe Gastrointestinal Stromal Tumor Market Size (2015-2020)
• 7.2 Gastrointestinal Stromal Tumor Key Players in Europe (2019-2020)
• 7.3 Europe Gastrointestinal Stromal Tumor Market Size by Type (2015-2020)
• 7.4 Europe Gastrointestinal Stromal Tumor Market Size by Application (2015-2020)

8 China

• 8.1 China Gastrointestinal Stromal Tumor Market Size (2015-2020)
• 8.2 Gastrointestinal Stromal Tumor Key Players in China (2019-2020)
• 8.3 China Gastrointestinal Stromal Tumor Market Size by Type (2015-2020)
• 8.4 China Gastrointestinal Stromal Tumor Market Size by Application (2015-2020)

9 Japan

• 9.1 Japan Gastrointestinal Stromal Tumor Market Size (2015-2020)
• 9.2 Gastrointestinal Stromal Tumor Key Players in Japan (2019-2020)
• 9.3 Japan Gastrointestinal Stromal Tumor Market Size by Type (2015-2020)
• 9.4 Japan Gastrointestinal Stromal Tumor Market Size by Application (2015-2020)

10 Southeast Asia

• 10.1 Southeast Asia Gastrointestinal Stromal Tumor Market Size (2015-2020)
• 10.2 Gastrointestinal Stromal Tumor Key Players in Southeast Asia (2019-2020)
• 10.3 Southeast Asia Gastrointestinal Stromal Tumor Market Size by Type (2015-2020)
• 10.4 Southeast Asia Gastrointestinal Stromal Tumor Market Size by Application (2015-2020)

11 India

• 11.1 India Gastrointestinal Stromal Tumor Market Size (2015-2020)
• 11.2 Gastrointestinal Stromal Tumor Key Players in India (2019-2020)
• 11.3 India Gastrointestinal Stromal Tumor Market Size by Type (2015-2020)
• 11.4 India Gastrointestinal Stromal Tumor Market Size by Application (2015-2020)

12 Central & South America

• 12.1 Central & South America Gastrointestinal Stromal Tumor Market Size (2015-2020)
• 12.2 Gastrointestinal Stromal Tumor Key Players in Central & South America (2019-2020)
• 12.3 Central & South America Gastrointestinal Stromal Tumor Market Size by Type (2015-2020)
• 12.4 Central & South America Gastrointestinal Stromal Tumor Market Size by Application (2015-2020)

13 Key Players Profiles

• 13.1 Novartis
  • 13.1.1 Novartis Company Details
  • 13.1.2 Novartis Business Overview
  • 13.1.3 Novartis Gastrointestinal Stromal Tumor Introduction
  • 13.1.4 Novartis Revenue in Gastrointestinal Stromal Tumor Business (2015-2020))
  • 13.1.5 Novartis Recent Development
• 13.2 ​​Sun Pharmaceutical
  • 13.2.1 ​​Sun Pharmaceutical Company Details
  • 13.2.2 ​​Sun Pharmaceutical Business Overview
  • 13.2.3 ​​Sun Pharmaceutical Gastrointestinal Stromal Tumor Introduction
  • 13.2.4 ​​Sun Pharmaceutical Revenue in Gastrointestinal Stromal Tumor Business (2015-2020)
  • 13.2.5 ​​Sun Pharmaceutical Recent Development
• 13.3 Pfizer
  • 13.3.1 Pfizer Company Details
  • 13.3.2 Pfizer Business Overview
  • 13.3.3 Pfizer Gastrointestinal Stromal Tumor Introduction
  • 13.3.4 Pfizer Revenue in Gastrointestinal Stromal Tumor Business (2015-2020)
  • 13.3.5 Pfizer Recent Development
• 13.4 Bayer Aktiengesellschaft
  • 13.4.1 Bayer Aktiengesellschaft Company Details
  • 13.4.2 Bayer Aktiengesellschaft Business Overview
  • 13.4.3 Bayer Aktiengesellschaft Gastrointestinal Stromal Tumor Introduction
  • 13.4.4 Bayer Aktiengesellschaft Revenue in Gastrointestinal Stromal Tumor Business (2015-2020)
  • 13.4.5 Bayer Aktiengesellschaft Recent Development
• 13.5 NATCO Pharma
  • 13.5.1 NATCO Pharma Company Details
  • 13.5.2 NATCO Pharma Business Overview
  • 13.5.3 NATCO Pharma Gastrointestinal Stromal Tumor Introduction
  • 13.5.4 NATCO Pharma Revenue in Gastrointestinal Stromal Tumor Business (2015-2020)
  • 13.5.5 NATCO Pharma Recent Development

14 Analyst's Viewpoints/Conclusions

15 Appendix

• 15.1 Research Methodology
  • 15.1.1 Methodology/Research Approach
  • 15.1.2 Data Source
• 15.2 Disclaimer